Adkar, S. S., Willard, V. P., Brunger, J. M., Shiao, K. T., Gersbach, C. A., & Guilak, F. (2016). 318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells. In Molecular Therapy (Vol. 24, pp. S128–S128). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)33127-6

Adkar, Shaunak S., Vincent P. Willard, Jonathan M. Brunger, Kenneth T. Shiao, Charles A. Gersbach, and Farshid Guilak. “318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells.” In Molecular Therapy, 24:S128–S128. Elsevier BV, 2016. https://doi.org/10.1016/s1525-0016(16)33127-6.

Adkar SS, Willard VP, Brunger JM, Shiao KT, Gersbach CA, Guilak F. 318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells. In: Molecular Therapy. Elsevier BV; 2016. p. S128–S128.

Adkar, Shaunak S., et al. “318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells.” Molecular Therapy, vol. 24, Elsevier BV, 2016, pp. S128–S128. Crossref, doi:10.1016/s1525-0016(16)33127-6.

Adkar SS, Willard VP, Brunger JM, Shiao KT, Gersbach CA, Guilak F. 318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells. Molecular Therapy. Elsevier BV; 2016. p. S128–S128.